Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q4 FY2020 Earnings Presentation
27 slides from Zota Health Care's earnings presentation, Jun 27, 2020
Slide 1: Investor Presentation cover letter to NSE
Lzoto' healthcare ltd. June 27 ,2020 To, The Manager ListinB Department, The National Stock Exchange of lndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai- 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: lnvestor Presentation Ref: Regulation 30 of sEBl (Listing obligations and D
Slide 2: Q4&FY20 Performance Highlights
Q4&FY20 PERFORMANCE HIGHLIGHTS JUNE 2020
Slide 3: Safe Harbor
Safe Harbor This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer d
Slide 4: Table Of Contents
Table Of Contents 1 Result Highlights 2 Operational Metrics 3 Davaindia 4 Business Outlook & Strategy 5 Financial Summary 3
Slide 5: Qtr- Result Highlights
A zoid Qtr- Result Highlights
Slide 6: Consol Quarterly Financial Highlights
Consol Quarterly Financial Highlights Q-o-Q 151.0 32.9 2,506.4 70.9 28.7 2,308.0 73.3 38.0 Q3-20 Q4-20 Q3-20 Q4-20 Q3-20 Q4-20 Q3-20 Q4-20 Revenues (Rs Lakhs) Gross Profit (%) Operating Profit (Rs Lakhs) PAT (Rs Lakhs) Y-o-Y 2,308.0 35.0 163.5 151.0 2,059.9 32.9 115.0 70.9 Q4-19 Q4-20 Q4-19 Q4-20 Q4
Slide 7: Revenue Break up – Quarterly
Revenue Break up – Quarterly Domestic Sales Dava India Sales 1,516.6 1,446.5 1,365.4 351.0 325.0 190.0 Q4-19 Q3-20 Q4-20 Q4-19 Q3-20 Q4-20 Export Sales (SEZ) 638.8 536.4 504.6 Q4-19 Q3-20 Q4-20 6
Slide 8: FY- Result Highlights
A zoid FY- Result Highlights
Slide 9: Consol Full Year Financial Highlights
Consol Full Year Financial Highlights Revenues (Rs Lakhs) Gross Profit (%) Operating Profit (Rs lakhs) 33.4 774.2 9,511.3 30.3 451.5 8,562.9 FY-19 FY-20 FY-19 FY-20 FY-19 FY-20 554.8 PAT (Rs lakhs) 274.1 FY-19 FY-20 8
Slide 10: Revenue Break up – Full Year
Revenue Break up – Full Year Domestic Sales Dava India Sales 6,308.9 6,157.2 1,213.4 598.0 FY-19 FY-20 FY-19 FY-20 Export Sales (SEZ) 1,988.9 1,807.7 FY-19 FY-20 9
Slide 11: Consol Profit & Loss Statement - Quarterly
Consol Profit & Loss Statement - Quarterly Particulars (Rs Lakhs) Q4FY20 Q4FY19 YoY % QoQ % Q3FY20 Export Sales (SEZ) 536.4 504.6 6.3 -16.0 638.8 Dava India Sales 325.0 190.0 71.1 -7.4 351.0 Domestic Sales 1,446.5 1,365.4 5.9 -4.6 1,516.6 Revenues from Operations 2,308.0 2,059.9 12.0 -7.9 2,506.4 Co
Slide 12: Profit & Loss Statement – Full Year
Profit & Loss Statement – Full Year Particulars (Rs Lakhs) FY20 FY19 YoY % Export Sales (SEZ) 1,988.9 1,807.7 10.0 Dava India Sales 1,213.4 598.0 102.9 Domestic Sales 6,308.9 6,157.2 2.5 Revenues from Operations 9,511.3 8,562.9 11.1 Cost of Goods Sold 6,630.0 5,701.4 16.3 Gross Profit 2,881.3 2,861.
Slide 13: Management Commentary
Management Commentary • In Q4FY20 turnover grew 12% YoY at Rs 2,308 Lakhs, continued to be driven by sales growth of Davaindia and exports market • Q4FY20 registered a 33% gross margins 200bps lower than Q4FY19 on the back of 15.7% YoY growth of RM cost • EBITDA at Rs 204 Lakhs 2% higher YoY, margin
Slide 14: Management Commentary: Domestic Operations and Exports
Management Commentary Domestic Operations • In Q4FY20 Domestic Revenues registered a growth of 14% YoY led by better volumes and realisations, while FY20 domestic revenues was up by11% over the prior year • In FY20 - EBITDA came in at Rs 240 Lakhs with margins at 3.2% • PAT at Rs 23 lakhs in FY20 Ex
Slide 15: Davaindia Generic Pharmacy
healthcare Itd. GY davaindia’ GENERIC PHARMACY
Slide 16: Davaindia Key Figures
Davaindia Key Figures Stores rolled-out Sales % 45 39 OTC/Cosmetics 17.7% 33 32 Cardiac & Diabetic 32.3% 28 29 29 Segments 0 17 Bill (%) 36% Avg Wallet Spends 32 (Rs) Q1FY19 Q2FY19 Q3FY19 Q4FY19 Q1FY20 Q2FY20 Q3FY20 Q4FY20 0 10 20 30 40 159 SKU’s No. of Customers Served Wallet Spent 152 330,000 136
Slide 17: Davaindia revenues gaining traction
• Operationally davaindia revenues are gaining traction are aligned as per the managements vision. Stronger growth in FY20 at 103% with an exhibition of efforts yielding fruit • Davaindia retail pharmacy stores is focus continues to be spread across chronic ailments – Cardiac, Diabetic, Thyroid etc
Slide 18: 17
17
Slide 19: Davaindia Footprints
Davaindia Footprints HARYANA (7) NEW DELHI (3) Yamunanagar, Kurukshetra, Bhiwani, Hisar,Faridabad UTTARAKHAND (2) Dehradun, Araghar RAJASTHAN (5) Jaipur, Jodhpur, Sikar, Shri Ganganagar UTTAR PRADESH (16) Jhansi,varanasi,,amroha,lucknow,ghaziabad Lalitpur. Prayagraj, mau, firozabad GUJARAT (103) Nad
Slide 20: Industry Snapshot & Business Strategy
Industry Snapshot & Business Strategy
Slide 21: Jan Aushadhi Stores and branded/generic mix
4 pillars to drive healthcare Branded and generic mix of Indian pharma market Jan Aushadhi Store s A key initiative against the high priced selling medicines in the market 20
Slide 22: Business Performance Outlook
Business Performance Outlook • Domestic business will grow at constant rate of 10% in FY21E, which will be a similar growth rate as previous year • Strong margin and geographic expansion of supplying medicines has put this division in a drivers seat to capture growth of 30%-40% in FY21E • As davaind
Slide 23: Business Performance Outlook
Business Performance Outlook • Manufacturing plant was remained shuttled from March 23, 2020 to April 16, 2020; due to this dispatches of goods to various countries have been affected. Business resumed in a phased manner w,e.f, April 17, 2020. • Export revenues being a higher margin business are exp
Slide 24: Financial Summary
ml ae Financial Summary A zoid
Slide 25: Profit & Loss Statement - Annually
Profit & Loss Statement - Annually Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 Income from Operations 5,011.2 5,646.3 6,473.3 7,158.0 7,785.2 8,562.9 9,511.3 Other Income 10.2 1.4 7.7 5.6 151.9 154.5 151.3 Total Income 5,021.4 5,647.8 6,481.0 7,163.6 7,937.0 8,717.4 9,662.6 Operating
Slide 26: Balance Sheet & Key Ratios
Balance Sheet & Key Ratios Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 Share capital 1,196.9 1,436.3 1,436.3 1,436.3 1,754.3 1,754.3 2,456.0 Reserves and Surplus 384.2 395.7 707.8 1,262.0 5,223.4 5,138.2 4,426.9 Non-current liabilities 521.3 548.7 272.7 466.8 64.7 87.1 105.3 Current l
Slide 27: Thank You
Contact Information Mr. Himanshu Zota / Mr. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002(Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com Thank You